NASDAQ:ODT

Odonate Therapeutics SEC Filings & 10K Form

$3.03
-0.02 (-0.66 %)
(As of 09/23/2021 10:44 AM ET)
Add
Compare
Today's Range
$3.03
$3.07
50-Day Range
$3.00
$3.84
52-Week Range
$2.80
$7.10
Volume1,410 shs
Average Volume2.24 million shs
Market Capitalization$116.66 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33

Odonate Therapeutics (NASDAQ:ODT) SEC Filings

DateFilerForm TypeView
08/05/2021
3:33 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2021
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2021
4:23 PM
EcoR1 Capital, LLC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13G
06/01/2021
3:30 PM
Odonate Therapeutics (Filer)
Form DEF 14A
05/14/2021
7:00 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2021
7:02 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/23/2021
7:28 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
7:11 AM
Odonate Therapeutics (Filer)
Form 424B5
02/23/2021
6:30 AM
Odonate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/17/2021
3:07 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
2:36 PM
JANUS HENDERSON GROUP PLC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13G
02/04/2021
10:35 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/05/2021
3:06 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:04 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
3:01 PM
Johnson Craig A (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:19 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:18 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
3:09 PM
Odonate Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
12/23/2020
3:41 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:01 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
3:15 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
3:06 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
3:06 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
3:05 PM
Johnson Laura L. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
3:04 PM
Odonate Therapeutics (Issuer)
Rosen Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
3:04 PM
Johnson Craig A (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
11:15 PM
Odonate Therapeutics (Filer)
Form EFFECT
12/02/2020
3:02 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:02 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:01 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:01 AM
Odonate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/04/2020
3:15 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
3:05 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:04 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/19/2020
3:04 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2020
3:01 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2020
3:01 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
3:36 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
3:31 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
3:01 PM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:13 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:12 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:09 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
4:59 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
4:59 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
8:10 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/02/2020
3:03 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:02 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:00 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:31 PM
Boxer Capital, LLC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13D/A
09/01/2020
3:30 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:30 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:14 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
7:17 AM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
5:01 AM
Odonate Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
08/26/2020
4:27 PM
Odonate Therapeutics (Filer)
Form 424B5
08/24/2020
3:01 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
3:03 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
3:03 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
3:02 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
7:08 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2020
3:22 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:20 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
7:00 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
3:27 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:27 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:26 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:14 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:14 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:13 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:00 AM
Odonate Therapeutics (Filer)
Form DEF 14A
04/28/2020
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/17/2020
3:17 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
3:12 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
7:01 AM
Odonate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2020
1:18 PM
FRANKLIN RESOURCES INC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13G/A
01/28/2020
8:57 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
12/12/2019
5:24 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:23 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:22 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:21 PM
Douglass Laura L. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:21 PM
Odonate Therapeutics (Issuer)
Rosen Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:20 PM
Johnson Craig A (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
8:01 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
5:04 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
5:03 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
5:02 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
7:12 AM
Odonate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/06/2019
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:11 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:11 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:10 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2019
11:15 PM
Odonate Therapeutics (Filer)
Form EFFECT
10/17/2019
4:46 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:45 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:44 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:02 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:01 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:01 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:40 PM
Odonate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.